Serotonin Levels in Atopic Dermatitis Patients
NCT03471819 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2018-03-22
Summary
Atopic dermatitis (AD) is a chronic pruritic inflammatory skin disease of unknown aetiology. Global prevalence rates range from 1%-20%.AD is often worsened by stress and anxiety.Plasma levels of 5-HT were found to be positively correlated with the disease severity.
Conditions
- Dermatologic Disease
Interventions
- DIAGNOSTIC_TEST
-
Serum serotonin level
blood sample will be obtained to evaluate serum level of serotonin
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Dalia A Negm, Lecturer · Assiut University
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-04-01
- Primary Completion
- 2019-03-31
- Completion
- 2019-04-30
More Related Trials
-
A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder
NCT00345098 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis
NCT00532519 ·Status: UNKNOWN ·Phase: NA
-
Repetitive Behavior Disorders in People With Severe Mental Retardation
NCT00491478 ·Status: UNKNOWN ·Phase: PHASE3
-
The Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDD
NCT02473783 ·Status: COMPLETED ·Phase: PHASE2
-
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
NCT00250614 ·Status: COMPLETED ·Phase: PHASE3
-
The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram
NCT00179257 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study on Effect of add-on Sulforaphane to SSRIs and Application of Niacin Skin Flush Response Test in Major Depressive Disorder
NCT05148169 ·Status: UNKNOWN ·Phase: PHASE4
-
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
NCT06081348 ·Status: RECRUITING ·Phase: PHASE2
-
Inflammatory Control of Antidepressant Efficacy: a Pharmaco-epigenetic Approach
NCT06306209 ·Status: RECRUITING
-
The Role of Inflammatory Processes in Development and Treatment of Depression
NCT03920475 ·Status: COMPLETED
-
Serotonin Selective Reuptake Inhibitor Treatment of Dual Diagnosis Post-traumatic Stress Disorder and Alcohol Problems
NCT02504931 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression
NCT00641108 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive Disorder
NCT01454635 ·Status: COMPLETED ·Phase: NA
-
Modulation of Visually Evoked Potentials by an Antidepressant
NCT00263133 ·Status: COMPLETED ·Phase: NA
-
Deprexil in Subjects With Signs and Symptoms of Depression
NCT01043367 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients
NCT00581009 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.
NCT02185131 ·Status: COMPLETED ·Phase: PHASE2
-
Benefits of Switching Antidepressants Following Early Nonresponse
NCT00519012 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Cholestatic Pruritus With Sertraline
NCT00058903 ·Status: COMPLETED ·Phase: PHASE2
-
Interpersonal Psychotherapy for Severely Depressed Inpatients
NCT00325000 ·Status: TERMINATED ·Phase: NA
-
Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis
NCT01001559 ·Status: COMPLETED
-
Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis
NCT00004300 ·Status: SUSPENDED ·Phase: PHASE2
-
Rhodiola Rosea Therapy of Major Depressive Disorder
NCT01098318 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Mild and Subthreshold Depressive Disorders
NCT00226642 ·Status: UNKNOWN ·Phase: PHASE4
-
Flushes and Sertraline Trial
NCT00283192 ·Status: COMPLETED ·Phase: NA